Home > Riviste > Italian Journal of Dermatology and Venereology > Fascicoli precedenti > Italian Journal of Dermatology and Venereology 2022 April;157(2) > Italian Journal of Dermatology and Venereology 2022 April;157(2):182-6

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

ORIGINAL ARTICLE   Free accessfree

Italian Journal of Dermatology and Venereology 2022 April;157(2):182-6

DOI: 10.23736/S2784-8671.21.07023-7

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Psychological impact of BRAF mutational status in advanced melanoma patients

Bernardo CARLI 1 , Eleonora CAMPOLMI 1, Isabella CIARDETTI 2, Raffaella GRIFONI 3, Serena SESTINI 4, Maria S. PINO 4, Lucia CALIGIANI 1, Lorenzo BORGOGNONI 4, Nicola PIMPINELLI 2

1 SOSD Psycho-oncology, USL Toscana Centro, Florence, Italy; 2 Department of Dermatology, Unit of Melanoma and Skin Cancer, USL Toscana Centro, Florence, Italy; 3 Unit of Melanoma and Skin Cancer, Department of Medical Oncology, USL Toscana Centro, Florence, Italy; 4 Department of Plastic Surgery, Unit of Melanoma and Skin Cancer, USL Toscana Centro, Florence, Italy



BACKGROUND: The aim of the study was to highlight the psychological aspects involved in patients with advanced melanoma and to describe the differences between subjects who are positive and negative for the BRAFv600e genetic mutation, a variable that leads to a different medical approach to cancer therapy. The hypothesis is that following knowledge of the genetic mutation and the therapeutic possibilities inherent to it, mutation positive patients (BRAF+) exhibit fewer negative psychological reactions than negative patients (BRAF-) at the time of diagnosis.
METHODS: The tests used (SF-12, MHQ) were administered at the time of diagnosis and after three months.
RESULTS: The main findings suggest a greater impairment of quality of life at T1 than at T0, regardless of the mutation; BRAF mutated patients show more favorable scores at diagnosis and a reversal of the trend at three months after diagnosis.
CONCLUSIONS: The results obtained, in line with the literature under review, show a significant general psychological distress in the present oncological sample, suggesting the importance of a psychological, as well as medical, care of the patient and the family.


KEY WORDS: Neoplasms; Psycho-oncology; Melanoma

inizio pagina